ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements
Mangalam Drugs and Organics Limited reported a combined default of ₹15.58 Crore on cash credit facilities from Bank of Maharashtra and Bank of Baroda. The defaults began in October 2025. The company stated it is making arrangements to pay the overdue amounts as soon as possible.
Shree Kishoriju Trading and Investments Private Limited, a promoter group entity of Mangalam Drugs & Organics Limited, announced the release of 5,08,599 pledged equity shares on February 6, 2026. This release represents 3.21% of the company's total share capital, reducing the encumbered holdings of the promoter group.
Mangalam Drugs & Organics Ltd submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate, issued by MUFG Intime India, confirms the processing and cancellation of share certificates received for dematerialisation during the quarter.